Information  X 
Enter a valid email address

Brave Bison Grp PLC (BBSN)

  Print   

Tuesday 11 August, 2020

Brave Bison Grp PLC

Change of Adviser

RNS Number : 7135V
Brave Bison Group PLC
11 August 2020
 

11 August 2020

 

Brave Bison Group plc

("Brave Bison", the "Company" and together with its subsidiaries the "Group")

 

Change of Adviser

 

Brave Bison Group plc (AIM: BBSN), the social video group, announces that Cenkos Securities plc has been appointed as the Company's nominated adviser and sole broker with immediate effect.

 

For further information please contact:

 

 

Brave Bison Group plc

Oliver Green, Executive Chairman

 

Via Rebecca Abigail Ltd

 

Cenkos Securities plc - Nominated Adviser & Broker

Nicholas Wells

Ben Jeynes

Harry Hargreaves

 

Tel: +44 (0)20 7397 8900

Rebecca Abigail Ltd - Media

Abigail Carrigan, Account Manager

Email:  [email protected]

 

Tel: +44 775 704 2837

 

 

About Brave Bison

 

Brave Bison is a social video group, specialising in cross-platform video content, connecting global audiences through social media. Its online communities reach over 135 million followers and the Brave Bison Studio provides expertise across strategy, research, data-driven insights, creative and production.

 

Brave Bison is one of the largest YouTube channel partners, with over 700 channels offering targeted inventory opportunities, alongside in-house specialists that deliver audience development and optimisation.

 

Its cultural connections and extensive networks have built the business long-standing client relationships with brands including P&G, Land Rover and Lego. With over 70 members of staff across London, Singapore, Japan and Korea, the 8-year-old business continues to stay at the forefront of this fast-moving digital age.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPDGGDIUXBDGGG

a d v e r t i s e m e n t